Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction

Cytokine

Volumn 26, Issue 2, 2004, Pages 89-93

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Garcia, Martin ^a   Ferrer, Julio ^a   De La Rosa, Alejandro ^a   Vargas, Manuel ^a   Reiter, Russel J ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Anti inflammatory; Interleukin; Light dark; Melatonin; Myocardial infarction

Indexed keywords

INTERLEUKIN 6; MELATONIN; PINEAL BODY HORMONE;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HORMONE RELEASE; HUMAN; INFLAMMATION; LIGHT DARK CYCLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VOLUNTEER;

CIRCADIAN RHYTHM; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MELATONIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PINEAL GLAND;

EID: 1642619150     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.01.003     Document Type: Article

References (33)

1. Vaddi K., Nicolini F.A., Mehta P. Increased tumor necrosis factor-α and interferon-γ secretion by mononuclear leukocytes in ischemic heart disease. J Am Coll Cardiol. 19:1992;240A.
2. Nilsson J. Cytokines and smooth muscle cells in atherosclerosis. Cardiovasc Res. 27:1993;1184-1190.
3. Muller J.E., Stone P.H., Turi Z.G., Rutherford J.D., Czeisler C.A., Parker C., et al. Circadian variation in the frequency of onset of acute myocardial infarction. The MILLIS Study Group. N Engl J Med. 313:1985;1315-1322.
4. Thompson D.R., Blandford R.L., Sutton T.W., Marchant P.R. Time of onset of chest pain in acute myocardial infarction. Int J Cardiol. 7:1985;139-148.
5. Abo T., Kawate K., Itoh K., Kumagai K. Studies on the bioperiodicity of the immune response. Circadian rhythms of human T, B and K cell traffic in the peripheral blood. J Immunol. 126:1981;1360-1366.
6. Levi F.A., Canon C., Touitou Y., Sulon J., Mechkouri M., Ponsart E.D., et al. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men. Clin Exp Immunol. 71:1988;329-335.
7. Jankovic B.D. Neuroimmunomodulation. From phenomenology to molecular evidence. Ann N Y Acad Sci. 741:1994;1-38.
8. Maestroni G.J.M., Conti A., Pierpaoli W. Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann N Y Acad Sci. 521:1988;140-148.
9. Guerrero J.M., Reiter R.J. Melatonin-immune system relationship. Curr Top Med Chem. 2:2002;167-179.
10. Arendt J. Melatonin. Clin Endocrinol. 29:1998;205-229.
11. Sothern R.B., Roitman-Johnson B., Kanabrocki E.L., Yager J.G., Roodel M.M., Weatherbee J.A., et al. Circadian characteristics of circulating IL-6 in men. J Allergy Clin Immunol. 95:1995;1029-1035.
12. Lemmer B., Schwulera U., Thrun A., Lissner R. Circadian rhythm of soluble interleukin-2 receptor in healthy individuals. Eur Cytokine Netw. 3:1992;335-336.
13. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev. 12:1991;151-180.
14. Brzezinski A. Melatonin in humans. N Engl J Med. 336:1997;186-195.
15. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia M.J., Sanchez J., Marrero F., de Armas-Trujillo D. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res. 33:2002;248-252.
16. Seino Y., Ikeda U., Ikeda M., Yamamoto K., Misawa Y., Hasegawa T., et al. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 6:1994;87-91.
17. Ancey C., Corby P., Froger J., Delwail A., Wijdenes J., Gascan H., et al. Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine. 18:2002;199-205.
18. Perez-Fernandez R., Kaski J.C. Interleucina-10 y enfermedad coronaria. Rev Esp Cardiol. 55:2002;738-750.
19. Schieffer B., Schieffer E., Hilfiker-Kleiner D., Hilfiker A., Kovanen P.T., Kaartinen M., et al. Expression of angiotensin II and interleukin-6 in human coronary atherosclerotic plaques. Potential implications for inflammation and plaque instability. Circulation. 101:2000;1372-1378.
20. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia M.J., de la Rosa A., Vargas M., Marrero F. Ritmo luz/oscuridad de las citocinas proinflamatorias en el infarto agudo de miocardio. Rev Esp Cardiol. 56:2003;555-560.
21. + cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol. 159:1997;574-581.
22. Garcia-Maurino S., Pozo D., Carrillo-Vico A., Calvo J.R., Guerrero J.M. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 65:1999;2143-2150.
23. Sutherland E.R., Martín R.J., Ellison M.C., Kraft M. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med. 166:2002;1055-1061.
24. Cuzzocrea S., Tan D.X., Costantino G., Mazzon E., Caputi A.P., Reiter R.J. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J. 13:1999;1930-1938.
25. Lissoni P., Rovelli F., Meregalli S., Fumagalli L., Musco F., Brivio F., et al. Melatonin as a new possible anti-inflammatory agent. J Biol Regul Homeost Agents. 11:1997;157-159.
26. 2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J. 17:2003;755-757.
27. Granger D.N. I/R injury: role of leukocyte-endothelial adhesion. News Physiol Sci. 12:1997;142-143.
28. Reiter R.J., Tan D.X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res. 58:2003;10-19.
29. Barnes P.J., Karin M. Nuclear factor-κβ. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1997;1066-1071.
30. Cuzzocrea S., Mazzon E., Serriano I., Lepore V., Terranova M.L., Ciccolo A., et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res. 30:2001;1-12.
31. Lezovalc'h F., Szaropani M., Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppresses the activity of the transcription factor NF Kappa B activation. FASEB J. 12:1998;685-693.
32. Reiter R.J., Calvo J.R., Karbownik M., Qi W., Tan D.X. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci. 917:2000;376-386.
33. López-Sendón J., López de Sá E. Nuevos criterios de diagnóstico de infarto agudo de miocardio: orden en el caos. Rev Esp Cardiol. 54:2001;669-674.